ロード中...

Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells

Programmed cell death ligand 1 (PD-L1) is a transmembrane protein that is expressed on tumor cells that suppresses the T cell-mediated immune response. Therapies targeting the PD-L1 pathway promote anti-tumor immunity and have shown promising results in some types of cancers. However, the functional...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Liao, Yunfei, Chen, Lulu, Feng, Yong, Shen, Jacson, Gao, Yan, Cote, Gregory, Choy, Edwin, Harmon, David, Mankin, Henry, Hornicek, Francis, Duan, Zhenfeng
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444742/
https://ncbi.nlm.nih.gov/pubmed/28415820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16326
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!